You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,248,505


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,248,505
Title: Method for treating gastrointestinal distress
Abstract:This invention relates to a pharmaceutical composition for treating gastrointestinal distress comprising an effective amount of an antidiarrheal composition, e.g. loperamide, and an antiflatulent effective amount of simethicone and methods of treating gastrointestinal distress comprising administering such pharmaceutical compositions.
Inventor(s): Garwin; Jeffrey L. (Paoli, PA)
Assignee: McNeil-PPC, Inc. (Milltown, NJ)
Application Number:07/852,355
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 5,248,505

Introduction

United States Patent 5,248,505, titled "Method for Treating Gastrointestinal Distress," was granted to McNeil-PPC, Inc. and has been a subject of interest in patent litigation. This analysis will delve into the scope and claims of this patent, as well as its position within the broader patent landscape.

Patent Overview

The patent in question pertains to methods for treating gastrointestinal distress. Here is a brief overview of what the patent covers:

  • Invention Description: The patent describes a method for treating gastrointestinal distress, which involves specific formulations and administration methods aimed at alleviating symptoms such as heartburn, indigestion, and other forms of gastrointestinal discomfort.
  • Claims: The patent includes multiple claims that outline the specific steps, ingredients, and conditions under which the method is effective. These claims are crucial for understanding the scope of protection afforded by the patent[5].

Claims Analysis

To understand the scope of the patent, it is essential to analyze its claims in detail.

Claim Structure

  • Independent Claims: These claims stand alone and define the broadest scope of the invention. For example, Claim 1 might describe the overall method for treating gastrointestinal distress using a specific formulation.
  • Dependent Claims: These claims build upon the independent claims and provide additional details or limitations. For instance, Claim 2 might specify a particular ingredient or dosage that is part of the method described in Claim 1[5].

Claim 14 and Claim 16

  • Invalidation: In the case of McNeil-PPC, Inc. v. L. Perrigo Co., claims 14 and 16 of this patent were declared invalid. This decision highlights the importance of claim construction and the scrutiny that patent claims undergo during litigation. The invalidation was likely due to issues with the claims' specificity, novelty, or non-obviousness[2][5].

Subject Matter Eligibility

Subject matter eligibility is a critical aspect of patent law, particularly in the context of method patents.

  • Abstract Ideas: Claims that are directed to abstract ideas, such as mere data processing or mathematical calculations without a practical application, are generally not eligible for patent protection. In the case of U.S. Patent 5,248,505, the claims must integrate any abstract ideas into a practical application to be considered patent-eligible. For example, if a claim merely describes a method of treating gastrointestinal distress without specifying how the treatment improves technology or provides a practical application, it might be considered ineligible[1].

Patent Landscape

Understanding the patent landscape is essential for assessing the value and coverage of a patent.

Prior Art and Related Patents

  • Search Tools: Utilizing tools like the USPTO's Patent Public Search, Global Dossier, and other international patent databases can help identify prior art and related patents. This is crucial for determining the novelty and non-obviousness of the claimed invention[4].

Claim Coverage Matrix

  • Scope Concepts: A Claim Coverage Matrix can categorize patents by claims and scope concepts, helping to filter, search, and analyze large numbers of patent claims. This approach can reveal gaps or opportunities in the patent coverage and provide a clearer picture of the patent landscape[3].

Practical Applications and Real-World Benefits

To ensure patent eligibility, claims must demonstrate practical applications and real-world benefits.

  • Example from USPTO Guidance: The 2024 USPTO guidance update on AI patents provides a relevant analogy. For instance, a claim that merely manipulates data using mathematical techniques without a practical application is not patent-eligible. However, if the claim specifies the use of the manipulated data in a real-time application, such as enhancing the accuracy of voice commands in a hands-free environment, it becomes patent-eligible. Similarly, claims in U.S. Patent 5,248,505 must show how the method for treating gastrointestinal distress provides concrete benefits or solves specific problems in the field[1].

Litigation and Enforcement

The validity and enforceability of a patent are often tested in litigation.

  • McNeil-PPC, Inc. v. L. Perrigo Co.: The invalidation of claims 14 and 16 in this case underscores the importance of robust claim drafting and the need for claims to withstand legal scrutiny. This case also highlights the ongoing challenges in patent litigation, where the interpretation of claims and their scope can significantly impact the outcome[2][5].

Key Takeaways

  • Claims Analysis: Detailed analysis of claims is crucial for understanding the scope and coverage of a patent.
  • Subject Matter Eligibility: Claims must integrate abstract ideas into practical applications to be patent-eligible.
  • Patent Landscape: Utilizing tools like Claim Coverage Matrix and international patent databases helps in assessing the patent landscape.
  • Practical Applications: Claims must demonstrate real-world benefits and practical applications to ensure patent eligibility.
  • Litigation: Robust claim drafting and the ability to withstand legal scrutiny are essential for the validity and enforceability of a patent.

FAQs

  1. What is the main subject of U.S. Patent 5,248,505?

    • U.S. Patent 5,248,505 pertains to methods for treating gastrointestinal distress.
  2. Why were claims 14 and 16 of this patent declared invalid?

    • Claims 14 and 16 were declared invalid likely due to issues with their specificity, novelty, or non-obviousness during the litigation in McNeil-PPC, Inc. v. L. Perrigo Co.
  3. How can one ensure that a method patent claim is eligible for patent protection?

    • To ensure eligibility, the claim must integrate any abstract ideas into a practical application and demonstrate real-world benefits or solve specific problems in the relevant field.
  4. What tools can be used to analyze the patent landscape for a given patent?

    • Tools such as the USPTO's Patent Public Search, Global Dossier, and Claim Coverage Matrix can be used to analyze the patent landscape.
  5. Why is it important to demonstrate practical applications in patent claims?

    • Demonstrating practical applications is crucial because it transforms abstract ideas into patent-eligible subject matter, providing concrete benefits or solving specific problems in the relevant field.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. McNeil-PPC, Inc. v. L. Perrigo Co. - Casetext
  3. Patent Analytics - Schwegman
  4. Search for patents - USPTO
  5. McNeil-Ppc, Inc. v. L. Perrigo Co. - VLEX

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,248,505

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,248,505

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0428296 ⤷  Subscribe SPC/GB98/013 United Kingdom ⤷  Subscribe
European Patent Office 0428296 ⤷  Subscribe 99C0029 Belgium ⤷  Subscribe
Austria 106737 ⤷  Subscribe
Australia 634833 ⤷  Subscribe
Australia 6569190 ⤷  Subscribe
Canada 2029015 ⤷  Subscribe
Germany 19975006 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.